SCHEMBL5694057

SCHEMBL5694057

CO[Si](OC)(OC)c1ccc(CN2C=CN(c3c(C)cc(C)cc3C)C2)cc1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5439308 0.99 MGAM (0.30) MGAMGAA
Hydrochloric Acid SCHEMBL5439273 0.99 MGAM (0.30) MGAMGAA
Bromide SCHEMBL5445825 0.87 — —
Hydrochloric Acid SCHEMBL5444912 0.87 — —
SCHEMBL5691748 0.87 MGAM (0.34) MGAM
Hydrochloric Acid SCHEMBL28712022 0.79 C5AR1 (0.40) GAA
SCHEMBL1046763 0.76 SLC22A12 (0.40) —
SCHEMBL5694051 0.75 — —
Hydrochloric Acid SCHEMBL1046187 0.75 SLC22A12 (0.40) —
Hydrochloric Acid SCHEMBL5441417 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270547-A1 N-heterocyclic carbenes that can be immobilized MERCK PATENT GMBH (DE) 2006-11-30 — — US disclosed
EP-1654265-A1 N-HETEROCYCLIC CARBENES THAT CAN BE IMMOBILIZED MERCK PATENT GmbH (DE) 2006-05-10 — — EP disclosed
WO-2005016941-A1 N-HETEROCYCLIC CARBENES THAT CAN BE IMMOBILIZED MERCK PATENT GMBH (DE) 2005-02-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270547-A1 N-heterocyclic carbenes that can be immobilized SIRT3, B3GNT2, SIRT2 MGAM 2073/4885GAA 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback